Skip to main content

Simpson Adam K.'s Form 4 filing

Icosavax, Inc. (ICVX) · filed Dec 23, 2022

Accession no.
0001209191-22-062666
Filed
Dec 23, 2022
Trade date
Dec 21-23, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $598.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Simpson Adam K.CIK 0001873839Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 21, 2022Common StockSSaleDisposed−66,764$8.96−$598,205.44225,105Direct
Dec 23, 2022Common StockMOption exerciseAcquired+14,369$0.84+$12,069.96239,474Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 23, 2022Common StockMOption exerciseDisposed−14,369$0.00$033,527Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)